
==== Front
Obes Pillars
Obes Pillars
Obesity Pillars
2667-3681
Elsevier

S2667-3681(24)00018-4
10.1016/j.obpill.2024.100116
100116
Article
Corrigendum to “Outcomes of concomitant antiobesity medication use with endoscopic sleeve gastroplasty in clinical US settings” [Obes. Pillars, Volume 11, September 2024, 100112]
Gala Khushboo a
Ghusn Wissam a
Brunaldi Vitor a
McGowan Christopher b
Sharaiha Reem Z. c
Maselli Daniel b
Vanderwel Brandon d
Kedia Prashant e
Ujiki Michael f
Wilson Eric g
Vargas Eric J. a
Storm Andrew C. a
Abu Dayyeh Barham K. abudayyeh.barham@mayo.edu
a⁎
a Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA
b True You Weight Loss, Cary, NC, USA
c Division of Gastroenterology and Hepatology, Weill Cornell Medicine, New York, USA
d Eviva, Shoreline, WA, USA
e Methodist Dallas Medical Center, Dallas, TX, USA
f NorthShore University Health System, Evanston, IL, USA
g University of Texas Health Science Center – Houston, Houston, TX, USA
⁎ Corresponding author. abudayyeh.barham@mayo.edu
29 6 2024
9 2024
29 6 2024
11 100116© 2024 The Author(s)
2024
https://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
==== Body
pmcThe authors regret two typographical errors in the graphical abstract:1) in the left column – “AOM use: 147, no AOM use: 1359”;

2) middle column, second-to-last line, should be “AOM >6 mo from ESG”.

The authors would like to apologise for any inconvenience caused.
